Skip to main content
Log in

Histaminasefreisetzung beim Kaninchen durch Heparin, andere Polyanionen und Protamin

Release of histaminase by heparin, other polyanions and protamine in the rabbit

  • Published:
Naunyn-Schmiedebergs Archiv für Pharmakologie Aims and scope Submit manuscript

Summary

The effects of heparin, some polyanions, and protamine on histaminase activity in plasma and in different organs of the rabbit were investigated.

  1. 1.

    Histaminase activity in plasma increases after injection of heparin in doses of 500 U/kg or more. The effect is approximately 25 times lower than that seen in the guinea pig with the same dose of heparin.

  2. 2.

    The release of the enzyme in slower in rabbits than in guinea pigs. Two peaks of activity were observed at 15 and 60 min, respectively, after heparin injection. The activity of the first peak was higher at pH 6.7 than at pH 7.4, while the reverse was true for the second peak. Under optimal pH conditions, the activity of the second peak reached a higher value than that of the first one. Incubation of plasma with EDTA-Na2 abolished the first peak whereas the second was not affected.

  3. 3.

    Release of histaminase by heparin is blocked by protamine in doses of 10 mg/kg or more at both peaks.

  4. 4.

    The increase of the histaminase activity in plasma after heparin is accompanied by a significant decrease of activity in the intestinal mucosa; in liver the decrease of enzyme activity is small in contrast to that observed in the guinea pig. The kidney is not involved in the release of histaminase.

  5. 5.

    An increase of histaminase activity is elicited by other polyanions. Relatively high doses, however, are required: 60 mg/kg dextran N 500, 5 mg/kg dextran N 10, 100 mg/kg polyethylensulfonate, and 5 mg/kg pentosanpolysulfate being the minimal doses.

    The release of histaminase öfter these drugs showed only one peak and the optimum pH for the activity was 7.4.

  6. 6.

    Protamine leads to increased histaminase activity in plasma when given in doses more than 6 times higher than is necessary for inhibiting the heparin effect on the enzyme activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Bernauer, W., Giertz, H., Hahn, F., Schmutzler, W., Seseke, G., Sievers, B. U.: Zum Mechanismus der Histaminaseaktivierung im anaphylaktischen Schock. Naturwissenschaften51, 412–413 (1964).

    Google Scholar 

  2. Buffoni, F.: Histaminase and related amine oxidases. Pharmacol. Rev.18, 1189 (1966).

    Google Scholar 

  3. Giertz, H., Hahn, F., Schmutzler, W., Seseke, G.: Histaminaseaktivierung durch Heparin und Protaminsulfat bei Meerschweinchen. Klin. Wschr.42 1034–1035(1964).

    Google Scholar 

  4. Hahn, F., Mészàros, E.: Effect of heparin, protamine sulfate, and antigen on histaminase (diaminoxydase) activity of the guinea pig liver. Arch. int. Pharmaoodyn.180, 195–205 (1969).

    Google Scholar 

  5. —, Schmutzler, W., Seseke, G., Giertz, H., Bernauer, W.: Histaminasefreisetzung durch Heparin und Protamin beim Meerschweinchen. Biochem. Pharmacol.15, 155–160 (1966).

    Google Scholar 

  6. Hansson, R., Thysell, H.: Diamine oxidase in blood plasma in some vertebrates and anodonta cygnea before and after injection of heparin. Acta physiol. scand.74, 533–542 (1968).

    Google Scholar 

  7. Kobayashi, Y., Kupelian, J., Maudsley, D. V.: Release of diamine oxidase by heparin in the rat. Biochem. Pharmacol.18, 1585–1591 (1969).

    Google Scholar 

  8. McEwen, M. O., Cohen, J. D.: An amine oxydase in normal human serum. J. Lab. clin. Med.62, 766–776 (1963).

    Google Scholar 

  9. Mitze, R., Pröhle, F., Degand, L., Hahn, F.: Änderungen in der histaminolytischen Aktivität der Meerschweinchenleber bei der Anaphylaxie. Changes of the histaminolytic activity of the guinea pig liver during the anaphylaxis. Naunyn-Schmiedebergs Arch. Pharmak.266, 406 (1970).

    Google Scholar 

  10. Rückardt, Ch., Perlick, E.: Pathologisch-anatomische Befunde nach Verabreichung von Dextransulfat und Carboxymethyldextransulfaten im Tierexperiment. Acta biol. med. germ.10, 126–146 (1963).

    Google Scholar 

  11. Schmutzler, W.: Studien über die Histaminase-Freisetzung beim Meerschweinchen im anaphylaktischen Schock und durch Histaminase-Liberatoren. Habilitationsschrift 1966.

  12. —: Das Verhalten der Histaminase, Diaminoxydase und Benzylaminoxydase im Blutplasma von Meerschweinchen und Mensch nach intravenöser Injektion von Heparin. Klin. Wschr.46, 953–956 (1968).

    Google Scholar 

  13. —, Giertz, H., Hahn, F., Seseke, G.: Zur Frage der Histaminaseaktivierung im anaphylaktischen Schock des Meerschweinchens. Kaunyn-Schmiedebergs Arch, exp. Path. Pharmak.250, 173 (1965).

    Google Scholar 

  14. —, Goldschmidt, O., Knop, J., Schaaff, R. P.: Untersuchungen über die Aminoxydase-Freisetzung ins Blut beim Meerschweinchen und Hund. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.255, 69–70 (1966).

    Google Scholar 

  15. —, Hahn, F., Goldschmidt, O., Seseke, G.: Untersuchungen über Substanzen mit histaminase-liberierender Wirkung beim Meerschweinchen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.255, 344–352 (1966).

    Google Scholar 

  16. ——, Seseke, G., Bernauer, W.: Über die Herkunft der Plasmahistaminase im anaphylaktischen Schock des Meerschweinchens. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.252, 332–338 (1966).

    Google Scholar 

  17. Wicksell, F.: A simplified method for estimating the histaminolytic activity of plasma in pregnancy. Acta physiol. scand.17, 359–369 (1949).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glanzmann, C., Glanzmann-Zapel, I. Histaminasefreisetzung beim Kaninchen durch Heparin, andere Polyanionen und Protamin. Naunyn-Schmiedebergs Arch. Pharmak. 268, 434–445 (1971). https://doi.org/10.1007/BF00997066

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00997066

Key-Words

Schlüsselwörter

Navigation